Skip to content

Usefulness of cardiac contrast magnetic resonance imaging for the evaluation of myocarditis complicated with dermatomyositis/polymyositis.

Usefulness of cardiac contrast magnetic resonance imaging for the evaluation of myocarditis complicated with dermatomyositis/polymyositis. - Usefulness of cardiac contrast MRI for myocarditis in dermatomyositis/polymyositis.

Status
Unknown
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000023789
Enrollment
20
Registered
2016-08-28
Start date
2016-08-29
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

dermatomyositis, polymyositis

Interventions

None listed

Sponsors

Division of Internal Medicine 2 Yamaguchi University Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The diagnosis of PM or DM is based on the criteria of Bohan and Peter criteria: 1) systemic muscle weakness, 2) increased serum muscle enzyme levels, 3) electromyographic (EMG) evidence of myopathic changes, 4) typical histologic findings in muscle biopsies, and/or 5) characteristic dermatologic manifestations of DM. The diagnosis is considered definite, probable, or possible according to the number of criteria fulfilled (at least 4, 3, or 2, respectively, including the dermatologic manifestations for diagnosis of DM), and patients with definite are included in the study.

Exclusion criteria

Exclusion criteria: 1) Patients who are considered to be complicated with muscle diseases other than dermatomyositis/ polymyositis. 2) Patients with a history of other myocarditis or cadiomyopathy, such as dilated cardiomyopathy and hypertrophic cadiomyopathy. 3) Patients who have been determined to be inappropriate as a study by the principal investigator.

Design outcomes

Primary

MeasureTime frame
Abnormal findings in the myocardium in the cardiac contrast MRI

Secondary

MeasureTime frame
Sensitivity and specificity of the cardiac contrast MRI of cardiomyopathy in patients with dermatomyositis/polymyositis. Risk factor of cardiomyopathy in patients with dermatomyositis/polymyositis

Countries

Japan

Contacts

Public ContactMakoto Kubo

Yamaguchi University Hospital Internal Medicine 2

mkubo@yamaguchi-u.ac.jp0836-22-2248

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026